Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 33342-173

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 33342-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 1000s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets containing 20 mg and 12.5 mg respectively. The film-coated tablets are provided by Macleods Pharmaceuticals Limited, manufactured for Macleods Pharma USA, Inc. The label includes storage instructions and dosage guidance references, with a package quantity of 1000 tablets.*

FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 100s)

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg strength. The label shows film-coated tablets in a 100 count (10 x 10 unit dose) package from Macleods Pharmaceuticals Limited, manufactured by Macleods Pharmaceuticals Ltd., India. It includes storage instructions and notes that the package is not child-resistant.*

FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 30s)

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide tablets, 20 mg/12.5 mg strength. The label shows the tablet count as 30 and states the product is manufactured for Macleods Pharma USA, Inc., Princeton, NJ and by Macleods Pharmaceuticals Ltd., Daman, India. Storage instructions and dosage references are also included.*

FDA Label Image

505 (Olmesartan Hctz 20 12 5mg 90s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, film-coated, 20 mg/12.5 mg strength. The label indicates 90 tablets per bottle, manufactured for Macleods Pharma USA, Inc. and by Macleods Pharmaceuticals Ltd in India. Storage instructions and dosage reference are also included on the label along with barcodes.*

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 1000s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, showing strength 40 mg/12.5 mg. The label indicates a film-coated tablet dosage form with a package size of 1000 tablets. The labeler is Macleods Pharma USA, Inc., with manufacturing by Macleods Pharmaceuticals Ltd., India. Storage instructions and usual dosage advisory are also noted on the label.*

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 100s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/12.5 mg by Macleods Pharmaceuticals Limited. The label shows a 100-tablet package (10 x 10 unit dose) with the NDC 33342-174-12. It includes manufacturer details, dosage strength, storage instructions, and a barcode.*

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 30s)

Pack label for Olmesartan Medoxomil and Hydrochlorothiazide tablets, film coated, with strengths of 40 mg and 12.5 mg respectively. The label shows it contains 30 tablets and is labeled by Macleods Pharmaceuticals Limited under Macleods Pharma USA, Inc. It includes storage instructions and states US prescription drug status.*

FDA Label Image

505 (Olmesartan Hctz 40 12 5mg 90s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/12.5 mg strength. The label displays the product name, strength, dosage form as tablets, and a package count of 90 tablets. It includes storage instructions and manufacturer details: Macleods Pharma USA, Inc., Princeton, NJ, and Macleods Pharmaceuticals Ltd., India. Barcodes are present on both sides of the label.*

FDA Label Image

505 (Olmesartan Hctz 40 25mg 1000s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg strength, film-coated oral tablets. The label indicates a package of 1000 tablets, manufactured by Macleods Pharmaceuticals Ltd., India, for Macleods Pharma USA, Inc. The label includes storage instructions and dosage advisory to consult prescribing information.*

FDA Label Image

505 (Olmesartan Hctz 40 25mg 100s)

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg by Macleods Pharmaceuticals Ltd. The label includes product name, strength, tablet count of 100 (10 x 10 unit dose), manufacturer information, storage instructions, and a barcode. The tablets are film coated and for oral use.*

FDA Label Image

505 (Olmesartan Hctz 40 25mg 30s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg strength, film-coated oral tablets. The package contains 30 tablets and is manufactured for Macleods Pharma USA, Inc. in Princeton, NJ, with manufacturing by Macleods Pharmaceuticals Ltd., Daman, India. The label includes storage instructions and dosage information reference.*

FDA Label Image

505 (Olmesartan Hctz 40 25mg 90s)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg strength. The film-coated oral tablets are manufactured by Macleods Pharmaceuticals Ltd., India, and labeled for Macleods Pharma USA, Inc. The label includes storage instructions, barcode, and indicates a package of 90 tablets.*

FDA Label Image

505 (Olmesartan Hctz Structure)

Chemical structure diagram of the active ingredient olmesartan medoxomil. The image shows the molecular framework including sulfonamide and chloro-substituted aromatic rings consistent with olmesartan medoxomil's structure.*

FDA Label Image

505 (Olmesartan Structure)

Chemical structure diagram of the active ingredient Olmesartan Medoxomil, showing various functional groups and molecular bonds characteristic of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.